Ann: Shareholder Update, page-3

I attended yesterday. It was a small group of investors. The vibe was very relaxed. A couple of catalysts are upcoming (NATA) as everyone is aware. The CEO was very upbeat about the final inspection and feedback. The lab itself is very economical size wise, with all the machinery in place to conduct testing immediately upon approval. They will probably roll out similar labs across each main city as the test gains momentum amongst doctors. Interesting they are really targeting the surgeons as they are the main influence in getting GP's to adopt the test. adoption typically starts slow and then eventually a tsunami as more and more generalists take up the tests. Exciting times!